臨床婦人科産科69巻1号

2015年01月発行

今月の臨床 ゲノム時代の婦人科がん診療を展望する─がんの個性に応じたpersonalizationへの道

【総論】

6．小児・思春期がんの妊孕性温存

著者： 吉岡伸人¹ 鈴木直¹

所属機関： ¹聖マリアンナ医科大学産婦人科学

ページ範囲：P.40 - P.45

文献概要

●がん治療成績の向上により小児がんサバイバーが増加しているため，妊孕性温存に対する関心が高まっている．

●小児・思春期がんの妊孕性温存は，婦人科診察の限界，MRD（卵巣組織内の遺残がん病巣）への注意が必要である．

●小児・思春期がん患者への妊孕性温存は問題点も多く，今後の検討・改善が必要である．

参考文献

1） Siegel R, et al : Cancer statistics, 2012. CA Cancer J Clin 62 : 10─29, 2012

2） Green M, et al : Fertility of female survivors of childhood cancer : a report from the childhood cancer survivor study. J Clin Oncol 27 : 2677─2685, 2009

3） Chen C : Pregnancy after human oocyte cryopreservation. Lancet 19 : 884─886, 1986

4） Fabbri R, et al : Oocyte cryopreservation. Hum Reprod 4 : 98─108, 1998

5） Elst JV, et al : Oocyte freezing : here to stay? Hum Reprod Update 9 : 463─470, 2003

6） Cobo A, et al : Use of cryo-banked oocytes in an ovum donation programme : a prospective, randomized, controlled, clinical trial. Hum Reprod 25 : 2239─2246, 2010

7） Potdar N, et al : Oocyte vitrification in the 21st century and post-warming fertility outcomes : a systematic review and meta─analysis. Reprod Biomed Online 29 : 159─176, 2014

8） Donnez J, et al : Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364 : 1405─1410, 2004

9） von Wolf M, et al : Cryopeservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy- A technique in its infancy but already successful in fertility preservation. Eur J Cancer 45 : 1547─1553, 2009

10） Dolmans MM, et al : IVF outcomes in patients with orthotopically transplanted ovarian tissue. Hum Reprod 24 : 2778─2787, 2009

11） Keros V, et al : Vitirification versus controlled-rate freezing in cryopreservation of human ovarian tissue. Human Reprod 24 : 1670─1683, 2009

12） Amorim CA, et al : Vitrification and xenografting of human ovarian tissue. Fertil Steril 98 : 1291─1298, 2012

13） Dolmans MM, et al : A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 30 : 305─314, 2013

14） Ajala T, et al : Fertility preservation for cancer patients ; a review. Obstet Gynecol Int 2010 : 160386, 2010

15） Rosendahi M, et al : Evidence of residual disease in cryopreserved ovarian tissue in cancer patients with leukemia. Fertil Steril 94 : 2186─2190, 2010

16） Ataya K, et al : Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide─lnduced ovarian follicular depletion in rhesus monkeys. Biol Reprod 52 : 365─372, 1995

17） Blumenfeld Z, et al : How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 12 : 1044─1054, 2007

18） Sugiyama M, et al : Gonadotropin-releasing hormone retards doxorubicin-induced apoptosis and serine/threonine phosphatase inhibition in ovarian cancer cells. Oncol Rep 13 : 813─817, 2005

19） Moore HCF, et al : Goserelin preserves fertility in young women with early ER-negative breast cancer. Oncology Times 36 : 8, 2014

20） Hagen CP, et al : Serum levels of anti-müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. J Clin Endocrinol Metab 95 : 5003─5010, 2010